Akebia Therapeutics Ownership 2024 | Who Owns Akebia Therapeutics Now?
Institutional Ownership
27.41%
Insider Ownership
2.17%
Retail Ownership
70.41%
Institutional Holders
106.00
Akebia Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.68% | 0.00% | 11,638,484 | 9,099,259 | 358.35% | 11,871,253 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.53% | 0.00% | 9,276,263 | 1,050,291 | 12.77% | 9,461,789 | Jun 30, 2024 |
| ALERCE INVESTMENT MANAGEMENT, L.P. | 2.80% | 11.49% | 5,747,906 | -7,457,213 | -56.47% | 5,862,864 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.21% | 0.00% | 4,536,292 | 2,717,345 | 149.39% | 4,627,473 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.98% | 0.01% | 4,063,383 | -1,246,372 | -23.47% | 4,143,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.91% | 0.01% | 3,914,800 | 262,700 | 7.19% | 3,993,096 | Jun 30, 2024 |
| STATE STREET CORP | 1.34% | 0.00% | 2,747,240 | 2,096,890 | 322.42% | 2,802,185,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.02% | 0.01% | 2,094,733 | 457,155 | 27.92% | 2,136,628 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.85% | 0.00% | 1,744,616 | -518,060 | -22.90% | 1,779,508 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.51% | 0.00% | 1,046,059 | 1,588 | 0.15% | 1,066,980 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.42% | 0.00% | 865,252 | -1,302 | -0.15% | 882,557,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.37% | 0.00% | 763,332 | -25,043 | -3.18% | 778,599 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.29% | 0.00% | 604,551 | 585,789 | 3122.21% | 616,642 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.28% | 0.00% | 570,974 | 491,170 | 615.47% | 582,393 | Jun 30, 2024 |
| FMR LLC | 0.26% | - | 541,509 | 38,265 | 7.60% | 552,340 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.21% | 0.00% | 436,886 | 102,713 | 30.74% | 445,624,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.19% | 0.00% | 380,535 | 380,535 | 100.00% | 388,146 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.17% | 0.00% | 348,918 | -1,064,735 | -75.32% | 355,897 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.12% | 0.00% | 247,069 | -776,206 | -75.86% | 252,010 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.12% | 0.00% | 247,060 | 242,134 | 4915.43% | 251,993 | Jun 30, 2024 |
Akebia Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 5.68% of the company's total share outstanding, currently valued at $11.87M. The top 10 institutional shareholders own together 22.84% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALERCE INVESTMENT MANAGEMENT, L.P. | 2.80% | 11.49% | 5,747,906 | -7,457,213 | -56.47% | 5,862,864 | Jun 30, 2024 |
| ORCHARD CAPITAL MANAGEMENT, LLC | 0.04% | 0.03% | 86,826 | -21,634 | -19.95% | 88,563 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.98% | 0.01% | 4,063,383 | -1,246,372 | -23.47% | 4,143,000 | Jun 30, 2024 |
| WEALTH EFFECTS LLC | 0.01% | 0.01% | 27,000 | - | - | 27,540 | Jun 30, 2024 |
| EAGLE WEALTH STRATEGIES LLC | 0.01% | 0.01% | 12,000 | - | - | 12,240 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.02% | 0.01% | 2,094,733 | 457,155 | 27.92% | 2,136,628 | Jun 30, 2024 |
| STATE OF WYOMING | 0.02% | 0.01% | 49,727 | 49,727 | 100.00% | 50,722 | Jun 30, 2024 |
| CEDRUS LLC | 0.01% | 0.01% | 13,700 | 13,700 | 100.00% | 13,974 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.91% | 0.01% | 3,914,800 | 262,700 | 7.19% | 3,993,096 | Jun 30, 2024 |
| COMPASS ION ADVISORS, LLC | 0.01% | 0.01% | 25,095 | - | - | 45,924 | Jun 30, 2024 |
| SYKON CAPITAL LLC | 0.01% | 0.01% | 15,000 | - | - | 15,300 | Jun 30, 2024 |
| INDEPENDENT WEALTH NETWORK INC. | 0.01% | 0.01% | 12,003 | - | - | 12,243 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.01% | 75,079 | 75,079 | 100.00% | 77,000 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.51% | 0.00% | 1,046,059 | 1,588 | 0.15% | 1,066,980 | Jun 30, 2024 |
| SAPIENT CAPITAL LLC | 0.10% | 0.00% | 200,000 | - | - | 204,000 | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 52,651 | -207,350 | -79.75% | 53,704 | Jun 30, 2024 |
| JAMES J. BURNS & COMPANY, LLC | 0.01% | 0.00% | 15,602 | - | - | 16,000 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.85% | 0.00% | 1,744,616 | -518,060 | -22.90% | 1,779,508 | Jun 30, 2024 |
| AMELIORA WEALTH MANAGEMENT LTD. | 0.00% | 0.00% | 5,615 | - | - | 5,727 | Jun 30, 2024 |
| RB CAPITAL MANAGEMENT, LLC | 0.00% | 0.00% | 10,000 | - | - | 10,200 | Jun 30, 2024 |
The largest Akebia Therapeutics shareholder by % of total assets is ALERCE INVESTMENT MANAGEMENT, L.P.. The company owns 5.75M shares of Akebia Therapeutics (AKBA), representing 11.49% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.68% | 0.00% | 11,638,484 | 9,099,259 | 358.35% | 11,871,253 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.21% | 0.00% | 4,536,292 | 2,717,345 | 149.39% | 4,627,473 | Jun 30, 2024 |
| STATE STREET CORP | 1.34% | 0.00% | 2,747,240 | 2,096,890 | 322.42% | 2,802,185,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.53% | 0.00% | 9,276,263 | 1,050,291 | 12.77% | 9,461,789 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.29% | 0.00% | 604,551 | 585,789 | 3122.21% | 616,642 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.28% | 0.00% | 570,974 | 491,170 | 615.47% | 582,393 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.02% | 0.01% | 2,094,733 | 457,155 | 27.92% | 2,136,628 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.19% | 0.00% | 380,535 | 380,535 | 100.00% | 388,146 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.91% | 0.01% | 3,914,800 | 262,700 | 7.19% | 3,993,096 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.12% | 0.00% | 247,060 | 242,134 | 4915.43% | 251,993 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 111,914 | 111,914 | 100.00% | 115,271 | Jun 30, 2024 |
| INVESCO LTD. | 0.06% | - | 129,786 | 103,951 | 402.37% | 132,382 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.21% | 0.00% | 436,886 | 102,713 | 30.74% | 445,624,000 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.05% | 0.00% | 101,100 | 101,100 | 100.00% | 103,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.04% | - | 88,884 | 88,653 | 38377.92% | 90,662 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.05% | - | 96,099 | 88,057 | 1094.96% | 98,021 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.04% | - | 77,640 | 77,640 | 100.00% | 79,193 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.01% | 75,079 | 75,079 | 100.00% | 77,000 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.04% | 0.00% | 71,697 | 71,697 | 100.00% | 73,131 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.06% | - | 126,648 | 66,748 | 111.43% | 130,000 | Jun 30, 2024 |
As of Jun 30 2024, Akebia Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 9.10M stocks of AKBA, valued at $11.87M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALERCE INVESTMENT MANAGEMENT, L.P. | 2.80% | 11.49% | 5,747,906 | -7,457,213 | -56.47% | 5,862,864 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.02% | - | 45,685 | -3,220,315 | -98.60% | 46,599 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.98% | 0.01% | 4,063,383 | -1,246,372 | -23.47% | 4,143,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.17% | 0.00% | 348,918 | -1,064,735 | -75.32% | 355,897 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.12% | 0.00% | 247,069 | -776,206 | -75.86% | 252,010 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.10% | 0.00% | 211,647 | -578,836 | -73.23% | 215,880 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.85% | 0.00% | 1,744,616 | -518,060 | -22.90% | 1,779,508 | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -428,549 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -398,247 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -240,000 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.02% | 0.00% | 38,555 | -216,109 | -84.86% | 39,326 | Jun 30, 2024 |
| MARATHON TRADING INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 52,651 | -207,350 | -79.75% | 53,704 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -186,232 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -140,925 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -137,742 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.04% | - | 72,603 | -137,397 | -65.43% | 74,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.11% | - | 227,144 | -128,312 | -36.10% | 231,686 | Jun 30, 2024 |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | - | - | - | -92,554 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -81,676 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -77,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Akebia Therapeutics's biggest institutional seller is ALERCE INVESTMENT MANAGEMENT, L.P.. The company sold -7.46M shares of AKBA, valued at $5.86M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NUVEEN ASSET MANAGEMENT, LLC | 0.19% | 0.00% | 380,535 | 380,535 | 100.00% | 388,146 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 111,914 | 111,914 | 100.00% | 115,271 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.05% | 0.00% | 101,100 | 101,100 | 100.00% | 103,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.04% | - | 77,640 | 77,640 | 100.00% | 79,193 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.04% | 0.00% | 71,697 | 71,697 | 100.00% | 73,131 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.03% | 0.00% | 54,157 | 54,157 | 100.00% | 55,240 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.02% | 0.00% | 33,144 | 33,144 | 100.00% | 34,000 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.01% | - | 21,113 | 21,113 | 100.00% | 21,535,000 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 20,380 | 20,380 | 100.00% | 20,788 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.01% | - | 20,066 | 20,066 | 100.00% | 21,000 | Jun 30, 2024 |
| NICOLET ADVISORY SERVICES, LLC | 0.01% | 0.00% | 20,000 | 20,000 | 100.00% | 21,600 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 17,967 | 17,967 | 100.00% | 18,057 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 15,073 | 15,073 | 100.00% | 15,374 | Jun 30, 2024 |
| XPONANCE, INC. | 0.01% | 0.00% | 13,701 | 13,701 | 100.00% | 13,975 | Jun 30, 2024 |
| CEDRUS LLC | 0.01% | 0.01% | 13,700 | 13,700 | 100.00% | 13,974 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 7,197 | 7,197 | 100.00% | 7,000 | Jun 30, 2024 |
| GPS WEALTH STRATEGIES GROUP, LLC | 0.00% | 0.00% | 3,625 | 3,625 | 100.00% | 3,698 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.00% | 0.00% | 2,000 | 2,000 | 100.00% | 2,040 | Jun 30, 2024 |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 300 | 300 | 100.00% | 306 | Jun 30, 2024 |
| LAUREL WEALTH ADVISORS LLC | 0.00% | - | 229 | 229 | 100.00% | 234 | Jun 30, 2024 |
Akebia Therapeutics's largest new institutional shareholder by number of shares is NUVEEN ASSET MANAGEMENT, LLC, purchased 380.54K shares, valued at $388.15K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EAM INVESTORS, LLC | - | - | - | -428,549 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -398,247 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -240,000 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -186,232 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -140,925 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -137,742 | -100.00% | - | Jun 30, 2024 |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | - | - | - | -92,554 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -81,676 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -77,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -68,475 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -58,700 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -47,100 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -44,678 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -43,545 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -41,920 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -34,600 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -32,073 | -100.00% | - | Jun 30, 2024 |
| CANNON GLOBAL INVESTMENT MANAGEMENT, LLC | - | - | - | -28,000 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -23,900 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -22,500 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -22,262 | -100.00% | - | Jun 30, 2024 |
| DRW SECURITIES, LLC | - | - | - | -21,000 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -20,678 | -100.00% | - | Jun 30, 2024 |
| TRADELINK CAPITAL LLC | - | - | - | -13,200 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -13,000 | -100.00% | - | Jun 30, 2024 |
| SYMMETRY INVESTMENTS LP | - | - | - | -12,400 | -100.00% | - | Jun 30, 2024 |
| AMERITAS ADVISORY SERVICES, LLC | - | - | - | -12,096 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -10,900 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -10,590 | -100.00% | - | Jun 30, 2024 |
| GRIMES & COMPANY, INC. | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| INDEPENDENT WEALTH NETWORK INC. | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -9,700 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -9,170 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -5,800 | -100.00% | - | Jun 30, 2024 |
| GUGGENHEIM CAPITAL LLC | - | - | - | -1,039 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -756 | -100.00% | - | Jun 30, 2024 |
| NBC SECURITIES, INC. | - | - | - | -690 | -100.00% | - | Jun 30, 2024 |
| CAPITAL ADVISORS, LTD. LLC | - | - | - | -320 | -100.00% | - | Jun 30, 2024 |
| HEXAGON CAPITAL PARTNERS LLC | - | - | - | -186 | -100.00% | - | Jun 30, 2024 |
Akebia Therapeutics's largest sold out institutional shareholder by shares sold is EAM INVESTORS, LLC, sold -0.43M shares, valued at -, as of undefined.
Akebia Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HARTFORD HLS SERIES FUND II INC | 3.34% | 820,204 | - | - | Dec 31, 2023 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.39% | 75,711 | - | - | Mar 28, 2024 |
| VANGUARD EXPLORER FUND | 0.38% | 4,698,164 | - | - | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.33% | 809,713 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.23% | 119,228 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.14% | 3,193 | - | - | Dec 31, 2023 |
| ALGER FUNDS | 0.09% | 90,000 | - | - | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.09% | 2,164,990 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.06% | 138,892 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.06% | 396,648 | - | - | Aug 31, 2023 |
| ETFis Series Trust I | 0.05% | 65,149 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.04% | 277,261 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.04% | 25,679 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.04% | 88,844 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,525,367 | - | - | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.02% | 46,579 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.02% | 241,442 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 7,939,047 | -1,976,153 | -19.93% | Mar 31, 2024 |
| Guardian Variable Products Trust | 0.02% | 297,995 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.02% | 17,800 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.02% | 3,952 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.02% | 492,750 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.01% | 259,253 | -78,795 | -23.31% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.01% | 164,028 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 63,714 | - | - | Mar 31, 2020 |
| CLEARWATER INVESTMENT TRUST | 0.01% | 103,765 | - | - | Mar 28, 2024 |
| JPMORGAN INSURANCE TRUST | 0.01% | 141,900 | - | - | Mar 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 33,360 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.01% | 296,313 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,625,838 | 45,464 | 2.88% | Feb 29, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.01% | 271,772 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 21,040 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 766,382 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 11,500 | - | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 460,883 | - | - | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 233,000 | - | - | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 1,822 | - | - | Feb 29, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 37,527 | - | - | Dec 31, 2023 |
| Columbia Funds Variable Series Trust II | 0.00% | 119,919 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 107,700 | -8,206 | -7.08% | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 559,343 | - | - | Jan 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 55,466 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 424,730 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 245,101 | - | - | Jan 31, 2024 |
| Federated Hermes Adviser Series | 0.00% | 16,898 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 55,775 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 1,181 | - | - | Apr 30, 2021 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 21,000 | - | - | Mar 28, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 79,804 | - | - | Jan 31, 2024 |
| LEGG MASON PARTNERS INVESTMENT TRUST | 0.00% | 80,300 | - | - | Mar 28, 2024 |
| GPS Funds I | 0.00% | 7,738 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 25,418 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 125,939 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 6,056 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 704,638 | - | - | Feb 29, 2024 |
| PUTNAM FUNDS TRUST | 0.00% | 252,300 | - | - | Jan 31, 2024 |
| BMO FUNDS, INC. | 0.00% | 56,171 | 56,171 | - | Aug 31, 2020 |
| JPMORGAN TRUST II | 0.00% | 1,203,900 | - | - | Feb 29, 2024 |
| Global X Funds | 0.00% | 49,609 | - | - | Jan 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 114,125 | - | - | Jan 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 874 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 2,414 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 71,573 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 77,106 | - | - | Mar 28, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 6,484 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 682,540 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 40,691 | - | - | Feb 29, 2024 |
| Pacer Funds Trust | 0.00% | 28,730 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 37,117 | - | - | Mar 31, 2024 |
| GLENMEDE FUND INC | 0.00% | 4,481 | - | - | Jan 31, 2024 |
| JPMorgan Trust I | 0.00% | 593,200 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 493,951 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 1,665 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 1,572,201 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 20,782 | - | - | Dec 31, 2023 |
| THRIVENT MUTUAL FUNDS | 0.00% | 34,785 | - | - | Mar 28, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 1,510 | - | - | Mar 28, 2024 |
| PUTNAM VARIABLE TRUST | 0.00% | 12,785 | - | - | Mar 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 5,200 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 3,730 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 7,320 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 610,900 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 6,256 | - | - | Feb 29, 2024 |
| PGIM ETF TRUST | 0.00% | 17,293 | - | - | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 1,063 | - | - | Dec 31, 2023 |
| RUSSELL INVESTMENT CO | 0.00% | 71,525 | -8,150 | -10.23% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 6,810 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 921 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 64,646 | - | - | Feb 29, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 69,836 | - | - | Jan 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 7,839,688 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 17,028 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 1,039 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 22,125 | 21,145 | 2157.65% | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 23,610 | - | - | Mar 28, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 187,897 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 160,293 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 168 | - | - | Dec 31, 2023 |
| FLEXSHARES TRUST | 0.00% | 10,904 | - | - | Jan 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 405,849 | - | - | Mar 28, 2024 |
Akebia Therapeutics's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 820.20K shares, compromising 3.34% of its total assets.
Akebia Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 106 | -15.87% |
| 31 Mar, 24 | 126 | 38.46% |
| 31 Dec, 23 | 91 | 13.75% |
| 30 Sep, 23 | 80 | -3.61% |
| 30 Jun, 23 | 83 | 18.57% |
| 31 Mar, 23 | 70 | -11.39% |
| 31 Dec, 22 | 79 | -5.95% |
| 30 Sep, 22 | 84 | -5.62% |
| 30 Jun, 22 | 89 | -35.97% |
| 31 Mar, 22 | 139 | 0.72% |
| 31 Dec, 21 | 138 | 10.40% |
| 30 Sep, 21 | 125 | -11.97% |
| 30 Jun, 21 | 142 | -4.05% |
| 31 Mar, 21 | 148 | -0.67% |
| 31 Dec, 20 | 149 | -9.15% |
| 30 Sep, 20 | 164 | -15.90% |
| 30 Jun, 20 | 195 | 19.63% |
| 31 Mar, 20 | 163 | 2.52% |
| 31 Dec, 19 | 159 | - |
| 30 Sep, 19 | 159 | -1.24% |
| 30 Jun, 19 | 161 | -8.52% |
| 31 Mar, 19 | 176 | 2.92% |
| 31 Dec, 18 | 171 | 28.57% |
| 30 Sep, 18 | 133 | -9.52% |
| 30 Jun, 18 | 147 | -3.92% |
| 31 Mar, 18 | 153 | 17.69% |
| 31 Dec, 17 | 130 | 5.69% |
| 30 Sep, 17 | 123 | 2.50% |
| 30 Jun, 17 | 120 | 27.66% |
| 31 Mar, 17 | 94 | -5.05% |
| 31 Dec, 16 | 99 | 6.45% |
| 30 Sep, 16 | 93 | -12.26% |
| 30 Jun, 16 | 106 | 6.00% |
| 31 Mar, 16 | 100 | 5.26% |
| 31 Dec, 15 | 95 | 14.46% |
| 30 Sep, 15 | 83 | 12.16% |
| 30 Jun, 15 | 74 | 17.46% |
| 31 Mar, 15 | 63 | 6.78% |
| 31 Dec, 14 | 59 | 13.46% |
| 30 Sep, 14 | 52 | 1.96% |
| 30 Jun, 14 | 51 | 1600.00% |
| 31 Mar, 14 | 3 | - |
As of 30 Jun 24, 106 institutions are holding Akebia Therapeutics's shares, representing a decrease of -15.87% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 56,188,189 | -1.49% |
| 31 Mar, 24 | 57,038,634 | 4.20% |
| 31 Dec, 23 | 54,737,421 | 7.65% |
| 30 Sep, 23 | 50,849,494 | 1.12% |
| 30 Jun, 23 | 50,284,843 | -3.26% |
| 31 Mar, 23 | 51,981,428 | -0.55% |
| 31 Dec, 22 | 52,267,987 | 0.33% |
| 30 Sep, 22 | 52,094,513 | -9.19% |
| 30 Jun, 22 | 57,368,889 | -29.11% |
| 31 Mar, 22 | 80,921,343 | -16.15% |
| 31 Dec, 21 | 96,510,589 | -1.36% |
| 30 Sep, 21 | 97,836,735 | -7.24% |
| 30 Jun, 21 | 105,475,583 | 5.79% |
| 31 Mar, 21 | 99,700,913 | -3.35% |
| 31 Dec, 20 | 103,154,031 | 1.92% |
| 30 Sep, 20 | 101,212,480 | -8.79% |
| 30 Jun, 20 | 110,971,051 | 20.34% |
| 31 Mar, 20 | 92,215,015 | 10.18% |
| 31 Dec, 19 | 83,693,585 | -1.16% |
| 30 Sep, 19 | 84,679,951 | -2.02% |
| 30 Jun, 19 | 86,428,481 | 2.65% |
| 31 Mar, 19 | 84,194,103 | 4.54% |
| 31 Dec, 18 | 80,540,386 | 97.40% |
| 30 Sep, 18 | 40,801,486 | -4.88% |
| 30 Jun, 18 | 42,896,119 | -0.43% |
| 31 Mar, 18 | 43,082,009 | 27.97% |
| 31 Dec, 17 | 33,664,717 | 11.69% |
| 30 Sep, 17 | 30,140,896 | 10.54% |
| 30 Jun, 17 | 27,265,837 | 26.71% |
| 31 Mar, 17 | 21,518,260 | 6.47% |
| 31 Dec, 16 | 20,211,138 | 3.33% |
| 30 Sep, 16 | 19,559,515 | -0.24% |
| 30 Jun, 16 | 19,606,242 | -7.14% |
| 31 Mar, 16 | 21,112,887 | 29.78% |
| 31 Dec, 15 | 16,268,241 | 7.39% |
| 30 Sep, 15 | 15,148,694 | 19.71% |
| 30 Jun, 15 | 12,654,303 | 69.51% |
| 31 Mar, 15 | 7,465,162 | -1.27% |
| 31 Dec, 14 | 7,561,457 | -0.07% |
| 30 Sep, 14 | 7,566,377 | 4.47% |
| 30 Jun, 14 | 7,242,852 | 6877.50% |
| 31 Mar, 14 | 103,803 | - |
Akebia Therapeutics (AKBA) has 56.19M shares outstanding as of 30 Jun 24, down -1.49% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 27.41% | 3.04% |
| 31 Mar, 24 | 30.04% | 3.55% |
| 31 Dec, 23 | 29.07% | 3.92% |
| 30 Sep, 23 | 27.22% | 3.67% |
| 30 Jun, 23 | 27.21% | 3.44% |
| 31 Mar, 23 | 28.13% | 3.44% |
| 31 Dec, 22 | 28.60% | 3.56% |
| 30 Sep, 22 | 28.33% | 2.90% |
| 30 Jun, 22 | 31.25% | 1.54% |
| 31 Mar, 22 | 45.06% | 1.33% |
| 31 Dec, 21 | 58.16% | 1.83% |
| 30 Sep, 21 | 56.30% | 1.32% |
| 30 Jun, 21 | 65.38% | 1.56% |
| 31 Mar, 21 | 64.82% | 1.17% |
| 31 Dec, 20 | 74.50% | 1.49% |
| 30 Sep, 20 | 70.62% | 1.07% |
| 30 Jun, 20 | 81.06% | 1.57% |
| 31 Mar, 20 | 71.82% | 1.44% |
| 31 Dec, 19 | 70.69% | 1.39% |
| 30 Sep, 19 | 71.24% | 1.33% |
| 30 Jun, 19 | 73.08% | 1.41% |
| 31 Mar, 19 | 71.92% | 1.51% |
| 31 Dec, 18 | 68.90% | 5.66% |
| 30 Sep, 18 | 34.91% | 2.59% |
| 30 Jun, 18 | 36.70% | 2.70% |
| 31 Mar, 18 | 36.86% | 4.44% |
| 31 Dec, 17 | 28.80% | 4.33% |
| 30 Sep, 17 | 25.79% | 4.74% |
| 30 Jun, 17 | 23.33% | 6.88% |
| 31 Mar, 17 | 18.41% | 6.16% |
| 31 Dec, 16 | 17.29% | 6.18% |
| 30 Sep, 16 | 16.73% | 5.95% |
| 30 Jun, 16 | 16.77% | 5.14% |
| 31 Mar, 16 | 18.06% | 9.32% |
| 31 Dec, 15 | 13.92% | 8.29% |
| 30 Sep, 15 | 12.96% | 11.06% |
| 30 Jun, 15 | 10.83% | 26.54% |
| 31 Mar, 15 | 6.39% | 15.26% |
| 31 Dec, 14 | 6.47% | 15.44% |
| 30 Sep, 14 | 6.47% | 16.86% |
| 30 Jun, 14 | 6.20% | 78575.45% |
| 31 Mar, 14 | 0.09% | - |
As of 30 Jun 24, Akebia Therapeutics is held by 27.41% institutional shareholders, representing a 3.04% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 52 | -28.77% |
| 31 Mar, 24 | 73 | 97.30% |
| 31 Dec, 23 | 37 | 32.14% |
| 30 Sep, 23 | 28 | -6.67% |
| 30 Jun, 23 | 30 | 7.14% |
| 31 Mar, 23 | 28 | 40.00% |
| 31 Dec, 22 | 20 | -33.33% |
| 30 Sep, 22 | 30 | -18.92% |
| 30 Jun, 22 | 37 | -44.78% |
| 31 Mar, 22 | 67 | 1.52% |
| 31 Dec, 21 | 66 | 13.79% |
| 30 Sep, 21 | 58 | -14.71% |
| 30 Jun, 21 | 68 | -2.86% |
| 31 Mar, 21 | 70 | 7.69% |
| 31 Dec, 20 | 65 | -31.58% |
| 30 Sep, 20 | 95 | -22.76% |
| 30 Jun, 20 | 123 | 48.19% |
| 31 Mar, 20 | 83 | 13.70% |
| 31 Dec, 19 | 73 | 12.31% |
| 30 Sep, 19 | 65 | -19.75% |
| 30 Jun, 19 | 81 | 5.19% |
| 31 Mar, 19 | 77 | -36.89% |
| 31 Dec, 18 | 122 | 100.00% |
| 30 Sep, 18 | 61 | -18.67% |
| 30 Jun, 18 | 75 | -18.48% |
| 31 Mar, 18 | 92 | 13.58% |
| 31 Dec, 17 | 81 | -1.22% |
| 30 Sep, 17 | 82 | 2.50% |
| 30 Jun, 17 | 80 | 95.12% |
| 31 Mar, 17 | 41 | -12.77% |
| 31 Dec, 16 | 47 | 2.17% |
| 30 Sep, 16 | 46 | -13.21% |
| 30 Jun, 16 | 53 | -18.46% |
| 31 Mar, 16 | 65 | 18.18% |
| 31 Dec, 15 | 55 | 3.77% |
| 30 Sep, 15 | 53 | -10.17% |
| 30 Jun, 15 | 59 | 78.79% |
| 31 Mar, 15 | 33 | -5.71% |
| 31 Dec, 14 | 35 | 29.63% |
| 30 Sep, 14 | 27 | -46.00% |
| 30 Jun, 14 | 50 | 1566.67% |
| 31 Mar, 14 | 3 | - |
52 institutional shareholders have increased their position in AKBA stock as of 30 Jun 24 compared to 73 in the previous quarter (a -28.77% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 24 | - |
| 31 Mar, 24 | 24 | 14.29% |
| 31 Dec, 23 | 21 | - |
| 30 Sep, 23 | 21 | -4.55% |
| 30 Jun, 23 | 22 | 57.14% |
| 31 Mar, 23 | 14 | -56.25% |
| 31 Dec, 22 | 32 | 14.29% |
| 30 Sep, 22 | 28 | -15.15% |
| 30 Jun, 22 | 33 | -19.51% |
| 31 Mar, 22 | 41 | 5.13% |
| 31 Dec, 21 | 39 | 18.18% |
| 30 Sep, 21 | 33 | -15.38% |
| 30 Jun, 21 | 39 | -11.36% |
| 31 Mar, 21 | 44 | -13.73% |
| 31 Dec, 20 | 51 | 18.60% |
| 30 Sep, 20 | 43 | - |
| 30 Jun, 20 | 43 | 4.88% |
| 31 Mar, 20 | 41 | -8.89% |
| 31 Dec, 19 | 45 | -2.17% |
| 30 Sep, 19 | 46 | 53.33% |
| 30 Jun, 19 | 30 | -42.31% |
| 31 Mar, 19 | 52 | 108.00% |
| 31 Dec, 18 | 25 | -37.50% |
| 30 Sep, 18 | 40 | 2.56% |
| 30 Jun, 18 | 39 | 2.63% |
| 31 Mar, 18 | 38 | 11.76% |
| 31 Dec, 17 | 34 | 88.89% |
| 30 Sep, 17 | 18 | -33.33% |
| 30 Jun, 17 | 27 | -18.18% |
| 31 Mar, 17 | 33 | 13.79% |
| 31 Dec, 16 | 29 | 26.09% |
| 30 Sep, 16 | 23 | -20.69% |
| 30 Jun, 16 | 29 | 45.00% |
| 31 Mar, 16 | 20 | -4.76% |
| 31 Dec, 15 | 21 | 31.25% |
| 30 Sep, 15 | 16 | 433.33% |
| 30 Jun, 15 | 3 | -78.57% |
| 31 Mar, 15 | 14 | - |
| 31 Dec, 14 | 14 | 16.67% |
| 30 Sep, 14 | 12 | - |
| 30 Jun, 14 | - | - |
| 31 Mar, 14 | - | - |
24 institutional shareholders have reduced their position in AKBA stock as of 30 Jun 24 compared to 24 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 106 | -15.87% | 56,188,189 | -1.49% | 27.41% | 3.04% | 52 | -28.77% | 24 | - |
| 31 Mar, 24 | 126 | 38.46% | 57,038,634 | 4.20% | 30.04% | 3.55% | 73 | 97.30% | 24 | 14.29% |
| 31 Dec, 23 | 91 | 13.75% | 54,737,421 | 7.65% | 29.07% | 3.92% | 37 | 32.14% | 21 | - |
| 30 Sep, 23 | 80 | -3.61% | 50,849,494 | 1.12% | 27.22% | 3.67% | 28 | -6.67% | 21 | -4.55% |
| 30 Jun, 23 | 83 | 18.57% | 50,284,843 | -3.26% | 27.21% | 3.44% | 30 | 7.14% | 22 | 57.14% |
| 31 Mar, 23 | 70 | -11.39% | 51,981,428 | -0.55% | 28.13% | 3.44% | 28 | 40.00% | 14 | -56.25% |
| 31 Dec, 22 | 79 | -5.95% | 52,267,987 | 0.33% | 28.60% | 3.56% | 20 | -33.33% | 32 | 14.29% |
| 30 Sep, 22 | 84 | -5.62% | 52,094,513 | -9.19% | 28.33% | 2.90% | 30 | -18.92% | 28 | -15.15% |
| 30 Jun, 22 | 89 | -35.97% | 57,368,889 | -29.11% | 31.25% | 1.54% | 37 | -44.78% | 33 | -19.51% |
| 31 Mar, 22 | 139 | 0.72% | 80,921,343 | -16.15% | 45.06% | 1.33% | 67 | 1.52% | 41 | 5.13% |
| 31 Dec, 21 | 138 | 10.40% | 96,510,589 | -1.36% | 58.16% | 1.83% | 66 | 13.79% | 39 | 18.18% |
| 30 Sep, 21 | 125 | -11.97% | 97,836,735 | -7.24% | 56.30% | 1.32% | 58 | -14.71% | 33 | -15.38% |
| 30 Jun, 21 | 142 | -4.05% | 105,475,583 | 5.79% | 65.38% | 1.56% | 68 | -2.86% | 39 | -11.36% |
| 31 Mar, 21 | 148 | -0.67% | 99,700,913 | -3.35% | 64.82% | 1.17% | 70 | 7.69% | 44 | -13.73% |
| 31 Dec, 20 | 149 | -9.15% | 103,154,031 | 1.92% | 74.50% | 1.49% | 65 | -31.58% | 51 | 18.60% |
| 30 Sep, 20 | 164 | -15.90% | 101,212,480 | -8.79% | 70.62% | 1.07% | 95 | -22.76% | 43 | - |
| 30 Jun, 20 | 195 | 19.63% | 110,971,051 | 20.34% | 81.06% | 1.57% | 123 | 48.19% | 43 | 4.88% |
| 31 Mar, 20 | 163 | 2.52% | 92,215,015 | 10.18% | 71.82% | 1.44% | 83 | 13.70% | 41 | -8.89% |
| 31 Dec, 19 | 159 | - | 83,693,585 | -1.16% | 70.69% | 1.39% | 73 | 12.31% | 45 | -2.17% |
| 30 Sep, 19 | 159 | -1.24% | 84,679,951 | -2.02% | 71.24% | 1.33% | 65 | -19.75% | 46 | 53.33% |
| 30 Jun, 19 | 161 | -8.52% | 86,428,481 | 2.65% | 73.08% | 1.41% | 81 | 5.19% | 30 | -42.31% |
| 31 Mar, 19 | 176 | 2.92% | 84,194,103 | 4.54% | 71.92% | 1.51% | 77 | -36.89% | 52 | 108.00% |
| 31 Dec, 18 | 171 | 28.57% | 80,540,386 | 97.40% | 68.90% | 5.66% | 122 | 100.00% | 25 | -37.50% |
| 30 Sep, 18 | 133 | -9.52% | 40,801,486 | -4.88% | 34.91% | 2.59% | 61 | -18.67% | 40 | 2.56% |
| 30 Jun, 18 | 147 | -3.92% | 42,896,119 | -0.43% | 36.70% | 2.70% | 75 | -18.48% | 39 | 2.63% |
| 31 Mar, 18 | 153 | 17.69% | 43,082,009 | 27.97% | 36.86% | 4.44% | 92 | 13.58% | 38 | 11.76% |
| 31 Dec, 17 | 130 | 5.69% | 33,664,717 | 11.69% | 28.80% | 4.33% | 81 | -1.22% | 34 | 88.89% |
| 30 Sep, 17 | 123 | 2.50% | 30,140,896 | 10.54% | 25.79% | 4.74% | 82 | 2.50% | 18 | -33.33% |
| 30 Jun, 17 | 120 | 27.66% | 27,265,837 | 26.71% | 23.33% | 6.88% | 80 | 95.12% | 27 | -18.18% |
| 31 Mar, 17 | 94 | -5.05% | 21,518,260 | 6.47% | 18.41% | 6.16% | 41 | -12.77% | 33 | 13.79% |
| 31 Dec, 16 | 99 | 6.45% | 20,211,138 | 3.33% | 17.29% | 6.18% | 47 | 2.17% | 29 | 26.09% |
| 30 Sep, 16 | 93 | -12.26% | 19,559,515 | -0.24% | 16.73% | 5.95% | 46 | -13.21% | 23 | -20.69% |
| 30 Jun, 16 | 106 | 6.00% | 19,606,242 | -7.14% | 16.77% | 5.14% | 53 | -18.46% | 29 | 45.00% |
| 31 Mar, 16 | 100 | 5.26% | 21,112,887 | 29.78% | 18.06% | 9.32% | 65 | 18.18% | 20 | -4.76% |
| 31 Dec, 15 | 95 | 14.46% | 16,268,241 | 7.39% | 13.92% | 8.29% | 55 | 3.77% | 21 | 31.25% |
| 30 Sep, 15 | 83 | 12.16% | 15,148,694 | 19.71% | 12.96% | 11.06% | 53 | -10.17% | 16 | 433.33% |
| 30 Jun, 15 | 74 | 17.46% | 12,654,303 | 69.51% | 10.83% | 26.54% | 59 | 78.79% | 3 | -78.57% |
| 31 Mar, 15 | 63 | 6.78% | 7,465,162 | -1.27% | 6.39% | 15.26% | 33 | -5.71% | 14 | - |
| 31 Dec, 14 | 59 | 13.46% | 7,561,457 | -0.07% | 6.47% | 15.44% | 35 | 29.63% | 14 | 16.67% |
| 30 Sep, 14 | 52 | 1.96% | 7,566,377 | 4.47% | 6.47% | 16.86% | 27 | -46.00% | 12 | - |
| 30 Jun, 14 | 51 | 1600.00% | 7,242,852 | 6877.50% | 6.20% | 78575.45% | 50 | 1566.67% | - | - |
| 31 Mar, 14 | 3 | - | 103,803 | - | 0.09% | - | 3 | - | - | - |
Akebia Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Akebia Therapeutics's stock was made by Hadas Nicole R. on May 14 2024, selling 12,016 shares at $1.26 per share (valued at $15.14K).
Akebia Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 14 | 2 | 700.00% |
| Q1 2024 | 14 | 10 | 140.00% |
| Q3 2023 | 2 | 1 | 200.00% |
| Q2 2023 | 20 | 4 | 500.00% |
| Q1 2023 | 7 | 19 | 36.84% |
| Q3 2022 | - | 1 | - |
| Q2 2022 | 16 | 1 | 1600.00% |
| Q1 2022 | 14 | 22 | 63.64% |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 12 | 8 | 150.00% |
| Q1 2021 | 21 | 10 | 210.00% |
| Q2 2020 | 16 | 5 | 320.00% |
| Q1 2020 | 14 | 4 | 350.00% |
| Q4 2019 | 6 | 1 | 600.00% |
| Q3 2019 | 2 | - | - |
| Q2 2019 | 24 | 6 | 400.00% |
| Q1 2019 | 12 | - | - |
| Q4 2018 | 28 | 6 | 466.67% |
| Q3 2018 | 2 | 1 | 200.00% |
14 total buy trades, and 2 total sell trades (buy/sell ratio of 7.00%) were made by Akebia Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 2 | - |
| Q1 2024 | - | 10 | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | 4 | - |
| Q1 2023 | - | 19 | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | 22 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | 8 | - |
| Q1 2021 | - | 8 | - |
| Q2 2020 | - | 4 | - |
| Q1 2020 | - | 4 | - |
| Q4 2019 | 6 | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | - | - | - |
| Q3 2018 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Akebia Therapeutics's stocks.
AKBA Ownership FAQ
Who Owns Akebia Therapeutics?
Akebia Therapeutics is owned by institutional shareholders (27.41%), insiders (2.17%), and public (70.41%). The largest institutional shareholder of Akebia Therapeutics is BLACKROCK INC. (5.68% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (3.34% of total shares).
Who are the major institutional shareholders of Akebia Therapeutics?
Akebia Therapeutics's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, ALERCE INVESTMENT MANAGEMENT, L.P., GEODE CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC. The top five shareholders own together 17.21% of the company's share outstanding.
How many Akebia Therapeutics shareholders are there?
As of Jun 2024, there are 106 institutional shareholders of Akebia Therapeutics.
What percentage of Akebia Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC owns 11.64M shares of Akebia Therapeutics, representing 5.68% of the company's total shares outstanding, valued at $11.87M (as of Jun 2024).
What percentage of Akebia Therapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 9.28M shares of Akebia Therapeutics (AKBA), compromising 4.53% of the company, valued at $9.46M.
What percentage of Akebia Therapeutics is owned by ALERCE INVESTMENT MANAGEMENT, L.P?
ALERCE INVESTMENT MANAGEMENT, L.P is the third largest holder of Akebia Therapeutics. The company owns 5.75M of the company's shares outstanding (worth $5.86M).